Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single-Dose Fasting Bioavailability Study of Mylan's Revefenacin Inhalation Solution, 175 mcg/3 mL in Healthy Chinese Adult Male and Female Volunteers

NCT05207111 is registered in ClinicalTrials.gov with Mylan Pharma UK Ltd. as lead sponsor.

NCT NCT05207111
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05207111 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single-Dose Fasting Bioavailability Study of Mylan's Revefenacin Inhalation Solution, 175 mcg/3 mL in Healthy Chinese Adult Male and Female Volunteers
Lead sponsor
Mylan Pharma UK Ltd.
Phase
Phase 1
Overall status
Completed
Start date
September 23, 2021
Completion date
September 30, 2021
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers bioavailability study